3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
56
Lung Neoplasms
48
Leukemia, Myeloid, Acute
44
Breast Neoplasms
37
Carcinoma, Non-Small-Cell Lung
36
Myelodysplastic Syndromes
27
Pancreatic Neoplasms
24
Leukemia, Lymphocytic, Chronic, B-Cell
24
Multiple Myeloma
23
Colorectal Neoplasms
23
Carcinoma, Renal Cell
22
Neoplasm Metastasis
20
Melanoma
20
Glioblastoma
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Ovarian Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
17
Brain Neoplasms
16
Triple Negative Breast Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
12
Carcinoma, Hepatocellular
12
Lymphoma, Mantle-Cell
11
Lymphoma, B-Cell
11
Leukemia, Myelomonocytic, Chronic
11
Fallopian Tube Neoplasms
11
Rectal Neoplasms
10
Myeloproliferative Disorders
10
Lymphoma, Follicular
10
Colonic Neoplasms
10
Hematopoietic and Lymphatic System Neoplasm
9
Interventions
Blood Specimen Collection
3
thymoglobulin
1
Ursodeoxycholic Acid
1
Transplantation
1
Surveys and Questionnaires
1
Specimen Handling
1
Restraint, Physical
1
Magnetic Resonance Spectroscopy
1
Diagnostic Tests, Routine
1
Cord Blood Stem Cell Transplantation
1
Circulating Tumor DNA
1
Celecoxib
1
Bone Marrow Transplantation
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Genetic Diseases, Inborn
×
Specimen Handling
×
Clear all
NCT05587439
2025-07-10
INHERIT
Dana-Farber Cancer Institute
Recruiting
500 enrolled